SCHEMBL20174718

SCHEMBL20174718

c1ccc2c(c1)-c1cccc(-c3nc(-c4ccncc4)nc(-c4ccncc4)n3)c1C21c2ccccc2-c2oc3ccccc3c21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.38
NPC1 O15118 5/20 0.38
RAB9A P51151 5/20 0.38
KDM4E B2RXH2 4/20 0.38
MAPT P10636 3/20 0.38
ALDH1A1 P00352 3/20 0.38
LMNA P02545 3/20 0.38
HPGD P15428 2/20 0.38
MAPK1 P28482 1/20 0.38
HSD17B10 Q99714 1/20 0.38
MAPK14 Q16539 1/20 0.38
HTT P42858 3/20 0.32
TSHR P16473 3/20 0.32
KMT2A Q03164 3/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C19 P33261 1/20 0.32
PKM P14618 1/20 0.32
PDE5A O76074 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20174208 0.88 ALDH1A1 (0.40) SMN1; SMN2NPC1RAB9AKDM4EMAPT
SCHEMBL20174272 0.87 MAPK14 (0.39) SMN1; SMN2NPC1RAB9AKDM4EMAPT
SCHEMBL20174412 0.84 SMN1; SMN2 (0.38) SMN1; SMN2NPC1RAB9AKDM4EMAPT
SCHEMBL20174292 0.81 MAPT (0.35) SMN1; SMN2KDM4EMAPTALDH1A1LMNA
SCHEMBL20174296 0.79 PDK2 (0.46) SMN1; SMN2NPC1RAB9AKDM4EMAPT
SCHEMBL20174200 0.78 MAPT (0.34) SMN1; SMN2KDM4EMAPTALDH1A1LMNA
SCHEMBL20174203 0.78 MAPT (0.33) SMN1; SMN2KDM4EMAPTALDH1A1LMNA
SCHEMBL20174205 0.78 ALOX5 (0.32) SMN1; SMN2KDM4EMAPTALDH1A1LMNA
SCHEMBL20174264 0.78 KMT2A (0.37) SMN1; SMN2KDM4EMAPTALDH1A1LMNA
SCHEMBL20174246 0.77 PLA2G2A (0.34) SMN1; SMN2KDM4EMAPTALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10738034-B2 Spiro compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2020-08-11 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10738034-B2 Spiro compound and organic light-emitting device comprising same CRY1, NR2E3, ERG SMN1; SMN2 3407/4885NPC1 2492/4885RAB9A 2250/4885
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, NR2E3, ERG SMN1; SMN2 3407/4885NPC1 2492/4885RAB9A 2250/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.